Lab List
• Richard Axel (che2107@columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. Codirector of the Zuckerman Institute. Dr. Axel won a Nobel Prize in 2004 for his groundbreaking work in decoding olfaction. Dr. Axel identified more than 1,000 special receptors in the nose that transmit olfactory information to the brain. https://www.axellab.columbia.edu/current-members
• Rudy Behnia (rb3161@columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. From Dr. Behnia’s webpage: “Rudy Behnia studies how our brains see the world around us. She focuses on the ways in which brain cells in the visual system process movement, such as a ball flying through the air. She is also interested in understanding how we can distinguish the colors of objects in our surroundings.” https://zuckermaninstitute.columbia.edu/rudy-behnia-phd
• Randy Bruno (rb2604@cumc.columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. From Dr. Bruno’s webpage: “The goal of the Bruno Lab's research is to define the underlying neural pathways and circuit elements that contribute to sensory perception: how information from the outside world is relayed to the neocortex, and how subsequent processing among cortical layers and thalamic nuclei contribute to perception, learning, remembering, and reasoning.” https://brunolab.neuroscience.columbia.edu/
• Jennifer Bussell (jbussell@gmail.com) Zuckerman Institute for Mind, Brain, and Behavior (Axel’s lab). From Dr. Bussell’s webpage: “I am studying the neural circuits underlying curiosity, information-seeking, and exploratory behavior in mammals.” http://www.jenniferbussell.org/
• Gwyneth Card (gc3017@columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. From Dr. Card’s webpage: “Gwyneth Card is interested in the neural mechanisms and circuit architectures that underlie visually guided behavioral choices in the fly.” https://www.neurosciencephd.columbia.edu/content/gwyneth-m-card
• Vincent Ferrera (vpf3@columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. From Dr. Ferrera’s webpage: “Vincent Ferrera studies attention and decision making. A main goal of his lab is to understand how the brain makes decisions when faced with incomplete information.” https://zuckermaninstitute.columbia.edu/vincent-p-ferrera-phd
• Anthony Fitzparick (anthony.fitzpatrick@columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. From Dr. Fitzpatrick’s webpage: “We leverage the latest developments in cryo-electron microscopy with complementary biophysical techniques (proteomics, light-microscopy, microfluidics) to explore the molecular and structural basis of neurodegeneration and memory.” https://www.fitzpatrick-lab.org/
• Nikolaus Kriegeskorte (nk2765@columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. From Dr. Kriegeskorte’s webpage: “I want to understand how our brains enable us to see. My lab uses deep neural networks, a brain-inspired artificial intelligence technology, to build computer models that can see and recognize objects in ways that are similar to biological visual systems.” https://kriegeskortelab.zuckermaninstitute.columbia.edu
• Jacqueline Gottlieb (jg2141@columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. From Dr. Gottlieb’s webpage: “Her interest is in how the brain gathers the evidence it needs — and ignores what it doesn’t — during everyday tasks and during special states such as curiosity.”https://zuckermaninstitute.columbia.edu/jacqueline-gottlieb-phd
• Stavos Lomvardas (sl682@columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. From Dr. Lomvardas’s webpage: “How can it be that there are 1,000 olfactory receptor genes in any given neuron, but only one gets expressed? When we understand how diversity works with olfactory receptor neurons, it affects not just our understanding of the senses, but how it shapes human behavior and development as a whole.”https://zuckermaninstitute.columbia.edu/stavros-lomvardas-phd
• Tom Maniatis (tm2472@cumc.columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. From Dr. Maniatis’s webpage: “Tom Maniatis pioneered the gene-cloning methods that gave a generation of scientists the tools necessary to identify the genes that cause disease. Today he uses advanced genetics and molecular and cellular biology to identify potential causes of neurological and neurodegenerative diseases such as ALS, also known as Lou Gehrig’s disease.” https://zuckermaninstitute.columbia.edu/tom-maniatis-phd
• Richard Mann (rsm10@columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. From Dr. Mann’s webpage: “The mechanisms that guide movement — even something as simple as how we put one foot in front of the other — are extraordinarily complex.” https://zuckermaninstitute.columbia.edu/richard-s-mann-phd
• Bianca Jones Marlin (bjm2174@columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. From Dr. Marlin webpage: “Do the experiences of your father leave a mark on your genes? Can trauma be passed down from generation to generation? Dr. Marlin has been combing the DNA of mice to explore these questions, bringing us one step closer to understanding our full genetic inheritance. https://www.biancajonesmarlin.com/
• Daniel Salzman (cds2005@columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. From Dr. Salzaman’s webpage: “Daniel Salzman explores why we often feel strong emotions in response to things we see. His ultimate goal is to map the brain circuitry that underlies emotion, as well as understand how this circuitry can go awry in psychiatric conditions, such as fear or panic disorders.” https://zuckermaninstitute.columbia.edu/daniel-salzman-md-phd
• Nathaniel Sawtell (ns2635@columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. From Dr. Sawtell’s webpage: “By studying electric fish, Nathaniel Sawtell is revealing the brain circuitry that filters our senses, allowing us to ignore unimportant information and focus on what matters.” https://zuckermaninstitute.columbia.edu/daniel-salzman-md-phd
• Steven Sieldelbaum (sas8@columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. From Dr. Siedelbaum’s webpage: ““The finding that the same small brain region controls both social memory and aggression came as a surprise. Are memory and aggression inexorably linked, or are they two separate functions of the same brain region? And do changes to CA2 also contribute to changes in aggression observed in psychiatric diseases such as schizophrenia? These are questions I’m eager to investigate.”https://zuckermaninstitute.columbia.edu/steven-siegelbaum-phd
• Andrew Tomlinson (at41@columbia.edu) Zuckerman Institute for Mind, Brain, and Behavior. From Dr. Tomlinson’s webpage: “Dr. Tomlinson explores how the cells that respond to light are made and assembled into a functioning retina. His work studies not just how eyes develop in each individual, but asks how those eyes have changed over the eons of evolution.” https://zuckermaninstitute.columbia.edu/andrew-tomlinson-phd
• Lila Davachi (ld24@columbia.edu) Columbia University Department of Psychology. From Dr. Davachi’s webpage: “In the lab, we want to understand how experiences are initially encoded, undergo further consolidation and are later retrieved. We use behavioral and neural (conventional and high-resolution fMRI, iEEG, MEG) measures to help us learn more about the cognitive and neural operations that contribute to episodic memory.” https://davachilab.psychology.columbia.edu/
• Daphna Shohamy (ds2619@columbia.edu) Columbia University Department of Psychology. From Dr. Shohamy’s webpage: “My research is focused on the intersection between learning, memory and decision making… I adopt an integrative approach that draws broadly on neuroscience to make predictions about cognition. Predictions are tested in behavioral and neuroimaging studies in healthy individuals, and in patients with isolated damage to specific brain systems.” https://psychology.columbia.edu/content/daphna-shohamy
• Michael Woodford (michael.woodford@columbia.edu) Columbia University Department of Psychology. From Dr. Woodford’s webpage: “The Cognition and Decision Lab is a joint venture among principal investigators Michael Woodford, Mark Dean and Hassan Afrouzi faculty members of the Economics Department at Columbia University. The lab's aim is to use tools and techniques from Economics, Neuroscience, and Psychology to better understand the cognitive processes underlying economic decision making.” https://www.cognition.econ.columbia.edu/
• Erin Barnhart (eb3305@columbia.edu) Columbia University Department of Biological Sciences. From Dr. Barnhart’s webpage: “We employ sophisticated imaging and genetic techniques to simultaneously measure and manipulate neuronal activity and subcellular elements within well-defined Drosophila motion vision circuits.” https://barnhartlab.org/
• Dalibor Sames (ds584@columbia.edu) Columbia University Department of Chemistry. From Dr. Sames’s webpage: “The Sames research group combines molecular design, organic chemical synthesis, and pharmacology to pursue important and exciting problems in neuroscience and CNS therapeutics development.” https://www.chem.columbia.edu/content/dalibor-sames
• Allison Lopatkin (alopatkin@barnard.edu) Barnard College Department of Biology. From Dr. Lopatkin’s webpage: “Research in our lab utilizes a systems microbiology approach to quantify and leverage ecological and evolutionary dynamics of microbial populations. Our ultimate goal is to develop alternative strategies that combat the rise of antibiotic resistant pathogens.” https://biology.barnard.edu/profiles/allison-lopatkin
• Allison Pischedda (apischedda@barnard.edu) Barnard College Department of Biology, From Dr. Pischedda’s webpage: “…Research in the Pischedda lab spans all levels of sexual interactions, from finding and choosing a mate to producing offspring.” https://www.pischeddalab.com/
• Kimberly Noble (Noble2@tc.columbia.edu) Teachers’ College Columbia University, From Dr. Noble’s webpage: “She is particularly interested in understanding how early in infancy or toddlerhood such disparities develop; the modifiable environmental differences that account for these disparities; and the ways we might harness this research to inform the design of interventions.” https://www.tc.columbia.edu/faculty/kgn2106/
• Lori Quinn (lq2165@tc.columbia.edu) Teachers’ College Columbia University. From Dr. Quinn’s webpage: “Dr. Quinn’s research has focused on evaluating motor control impairments and developing evidence and clinical guidelines for physical activity and exercise in neurodegenerative diseases, and in particular for people with Huntington's disease (HD) and Parkinson’s disease.” https://www.tc.columbia.edu/neurorehab/
• Alex Dranovsky (ad722@columbia.edu) Columbia University Medical Center Department of Neuroscience. From Dr. Dranovsky’s webpage: “Our lab is focused on deciphering how stressful and enriching experiences produce lasting changes in the postnatal brain, and how such changes can predict adaptive and maladaptive behaviors.” https://www.neurosciencephd.columbia.edu/content/alex-dranovsky-md-phd
• Christoph Anacker (ca2635@cumc.columbia.edu) Columbia University Department of Psychiatry. From Dr. Anacker’s webpage: Psychological stress is a major risk factor for the pathogenesis of psychiatric disorders, especially anxiety and depression. However, the neurobiological mechanisms by which stress changes the brain to cause differences in mood and behavior remain elusive. To investigate these mechanisms at the molecular and cellular level, our lab combines neural circuit approaches with molecular techniques in transgenic mice, including in vivo calcium imaging, optogenetics, chemogenetics, next generation sequencing, and epigenetic analyses.” https://anackerlab.com/
• Caroline Arout (caa2186@columbia.edu) Columbia University Department of Psychiatry. From Dr. Arout’s webpage: “Her interests continue to focus on the intersection of pain and substance use… Her overarching goal is to identify a more effective, less abuse-prone pharmacological treatment regime for chronic pain.” https://chosen.columbia.edu/directory/caroline-arout
• Mark Ansorge (mansorge@yahoo.com) Columbia University Department of Psychiatry. From Dr. Ansorge’s webpage: “…many genetic, epigenetic, and environmental factors interact to affect brain development to modulate risk for disorders later in life… We have found that one such crucial factor is serotonin…” https://www.columbiapsychiatry.org/profile/mark-ansorge-phd
• Kevin Bath (Kevin.Bath@nyspi.columbia.edu) Columbia University Department of Psychiatry. From Bath lab's webpage: The focus of the lab is to understand how adverse experiences encountered early in life alter the trajectory of neural development and the genetic mechanisms supporting those changes. We seek to understand this question through an evolutionary lens, and attempt to understand how changes in the timing of regional brain development support the proximate goals of survival and reproduction, with implications for expressions of pathological behavior.” https://www.bathlab.net
• Maura Boldrini (mb928@cumc.columbia.edu) Columbia University Department of Psychiatry. From Dr. Boldrini’s webpage: “My research focuses on studying stem cells and their progeny in the human adult brain in the context of psychiatric, neurodevelopmental and neurodegenerative disorders.” https://www.neurosciencephd.columbia.edu/content/maura-boldrini-md-phd
• Sarah Canetta (ses2119@cumc.columbia.edu) Columbia University Department of Psychiatry..From Dr. Canetta’s webpage: “My laboratory investigates the neural circuitry of cognitive and affective behaviors, with a particular focus on how experiences encountered during ‘sensitive periods’ shape the development of this circuitry and impact behavior all the way into adulthood.” https://www.columbiapsychiatry.org/profile/sarah-canetta-phd
• Muhammad Choran (muhammad.chohan@nyspi.columbia.edu) Columbia University Department of Psychiatry. From Dr. Choran’s webpage: “Dr. Chohan hopes to draw on his clinical background and research training to develop new approaches to understanding and treating the cognitive, motivational, and motor abnormalities that are characteristic of neuropsychiatric disorders.” https://www.columbiapsychiatry.org/profile/muhammad-o-chohan-md
• Christine Ann Denny (cad2125@cumc.columbia.edu) Columbia University Department of Psychiatry. From Dr. Denny’s webpage: “…we are using… mice to investigate what happens to hippocampal memory traces in normal, aged, and Alzheimer’s diseased mice. By combining this unique murine line with disease models and optogenetic reporter lines, we hope to identify the altered memory circuits in these conditions and how to manipulate them in order to improve memory retrieval. We hope that these studies may halt, or even reverse, the process of Alzheimer's disease-related memory loss or cognitive ageing. In a second line of research, we are also interested in understanding how rapid-acting antidepressants, such as ketamine, are able to improve mood and depressive-like behavior.” https://www.columbiapsychiatry.org/profile/christine-denny-phd#overview
• Suzette Evans (se18@cumc.columbia.edu) Columbia University Department of Psychiatry. From Dr. Evans’s webpage: “Dr. Suzette Evans is the Director of the Women’s Research Center in the Division on Substance Abuse, with Dr. Stephanie Collins Reed as the Co-Director. The primary research focus is related to women’s health issues specifically related to substance abuse and the menstrual cycle.” https://www.columbiapsychiatry.org/profile/suzette-evans-phd
• William P. Fifer (wpf1@cumc.columbia.edu) Columbia University Department of Psychiatry. From Dr. Fifer's webpage: “Dr. Fifer’s research interests focus on fetal and neonatal behavioral, physiological and central nervous system development. Current investigations in his laboratory include studies of fetal, newborn and premature infant neurobehavioral responses to environmental stimulation during sleep and the effects of prenatal exposures on later neurodevelopment.” https://www.columbiapsychiatry.org/profile/william-fifer-phd
• Richard Foltin (rwf2@cumc.columbia.edu) Columbia University Department of Psychiatry. From Dr. Foltin's webpage: “Research in drug abuse and eating behavior specializing in controlled laboratory studies in humans and laboratory animals with an expertise in cocaine and marijuana abuse.” https://www.columbiapsychiatry.org/profile/richard-foltin-phd
• Jay Gingrich (jay.gingrich@gmail.com) Columbia University Department of Psychiatry. From Dr. Gingrich’s webpage: “The mouse represents the most tractable experimental model of vertebrate behavior and brain function currently available. We use genetic, pharmacologic, environmental, and other manipulations to probe mechanisms underlying normal and abnormal behaviors that have relevance to neuropsychiatry.” https://www.columbiapsychiatry.org/profile/jay-gingrich-md
• Guillermo Horga (guillermo.horga@nyspi.columbia.edu) Columbia University Department of Psychiatry. From Dr. Horga’s webpage: “Psychosis is characterized by the experience of abnormal percepts, such as hallucinations, and delusional beliefs. While excessive dopamine transmission in the striatum is known to play a role in these symptoms, the cognitive and computational mechanisms mediating psychotic experiences remain unclear. To understand these neural mechanisms, our research uses behavioral paradigms and computational tools in combination with a variety of functional, structural and molecular in vivo neuroimaging techniques.” https://www.columbiapsychiatry.org/profile/guillermo-horga-md
• Jonathan Javitch (jaj2@columbia.edu) Columbia University Department of Psychiatry. From Dr. Javitch’s webpage: “One main line of research in my laboratory is aimed at understanding the structural bases of agonist and antagonist binding and specificity in the dopamine D2-like receptors and related biogenic amine receptor, how agonist binding is transduced into G protein activation, and the structural basis for G protein-coupled receptor (GPCR) oligomerization and its role in signaling.” https://www.columbiapsychiatry.org/profile/jonathan-javitch-md
• Jae-eun Kang-Miller (jkm2149@cumc.columbia.edu(link sends e-mail) Columbia University Department of Psychiatry. From Dr. Kang-Miller’s webpage: “We directly image neural circuits with single cell resolution in models for neuropsychiatric illness and treatment. Our projects focus on two leading causes of disability and mortality worldwide – major depressive disorder and Alzheimer’s disease.” https://www.kangmillerlab.com/
• Christoph Kellendonk (ck491@columbia.edu) Columbia University Department of Psychiatry. From Dr. Kellendok’s webpage: “Our laboratory uses mouse genetic tools in an effort to understand the biology that underlies the symptoms of schizophrenia.” https://www.columbiapsychiatry.org/research-labs/kellendonk-lab
• Marie Labouesse (mal2307@cumc.columbia.edu) Columbia University Department of Psychiatry (Kellendonk’s Lab). “Our laboratory uses mouse genetic tools in an effort to understand the biology that underlies the symptoms of schizophrenia.” https://www.columbiapsychiatry.org/research-labs/kellendonk-lab
• Rachel Marsh (rachel.marsh@nyspi.columbia.edu) Columbia University Department of Psychiatry. From Dr. Marsh’s webpage: “The Cognitive Development and Neuroimaging Lab (CDNL), directed by Dr. Rachel Marsh, focuses on identifying alterations in the neurodevelopmental trajectories of self-regulatory control processes.” https://www.columbiapsychiatry.org/profile/rachel-marsh-phd
• Kelly Martyniuk (kmm2295@cumc.columbia.edu) Columbia University Department of Psychiatry (Kellendonk’s Lab). From Dr. Kellendonk’s webpage: “Our laboratory uses mouse genetic tools in an effort to understand the biology that underlies the symptoms of schizophrenia.” https://www.columbiapsychiatry.org/research-labs/kellendonk-lab
• Rebecca Muhle (ram76@cumc.columbia.edu Columbia University Department of Psychiatry. From Dr. Muhle’s webpage: “Dr. Muhle's scientific research aims to uncover molecular genetic pathways that increase the likelihood of neurodevelopmental disorders such as autism, by utilizing high-throughput genomics methods in mouse and human model systems to examine the effects of disruptions of implicated genes.” https://muhlelab.org/pages/team
• Gaurav Patel (ghp2114@cumc.columbia.edu) Columbia University Department of Psychiatry. From Dr. Patel’s webpage: “His research interest is in the neural systems underlying social cognition, and how they become dysfunctional in psychiatric disorders such as schizophrenia.” https://www.columbiapsychiatry.org/profile/gaurav-h-patel-md#overview
• Eleanor Simpson (eleanor.simpson@nyspi.columbia.edu) Columbia University Department of Psychiatry. From Dr. Simpson’s webpage: ”Dr. Simpson’s laboratory uses transgenic, viral and chemogenetic manipulations in mice to test hypothesis-driven ideas about neurobiological mechanisms underlying behavior.” https://www.columbiapsychiatry.org/profile/eleanor-simpson-phd
• Kally Sparks (kally.sparks@nyspi.columbia.edu) Columbia University Department of Psychiatry. From Dr. Sparks’s webpage: “Her work involves investigation of neuroanatomical and molecular development of the hippocampus as well as examining the structure and function of the adult hippocampus after abnormal development.” https://www.columbiapsychiatry.org/profile/kally-sparks
• Bin Xu (bx2105@cumc.columbia.edu) Columbia University Department of Psychiatry. From Dr. Xu’s webpage: “My main research interests lie in two directions: 1). Identifying genetic mutations with large effects through high throughput deep sequencing. 2). Determining the impact of rare genetic mutations in pathophysiology of major neuropsychiatric disorders using human induced pluripotent stem cells (iPSC) based disease model.” https://www.columbiapsychiatry.org/profile/bin-xu-phd
• Adam Brickman (amb2139@cumc.columbia.edu) Columbia University Neurological Institute. From Dr. Brickman’s webpage: “he uses structural magnetic resonance imaging (MRI) to try to identify specific areas in the brain or coordinated patterns of brain tissue that are most vulnerable to the effects of age.” http://www.columbianeuroresearch.org/taub/faculty-brickman.html
• Dritan Agalliu (da191@cumc.columbia.edu) Columbia University Department of Neurology. From Dr. Agalliu’s webpage: “The Agalliu laboratory is investigating several fundamental issues in the biology of the mammalian blood-brain barrier.” https://www.neurology.columbia.edu/research/research-labs/agalliu-lab
• Sylvie Goldman (sg3253@cumc.columbia.edu) Columbia University Department of Neurology. From Dr. Goldman’s webpage: “Dr. Goldman's research interests focus on repetitive behaviors and, more specifically, on motor stereotypies in children with Autism Spectrum Disorders (ASD) and Rett Syndrome.” https://www.columbianeurology.org/profile/goldmans
• Marla Hamberger (mh61@cumc.columbia.edu) Columbia University Department of Neurology. From Dr. Hamberger’s webpage: “Dr. Hamberger's research involves language and memory from childhood through late adulthood in epilepsy, and her studies on brain mapping of language and preservation of language function following epilepsy surgery.” https://www.columbianeurology.org/profile/mjhamberger
• Martin Picard (mp3484@cumc.columbia.edu) Columbia University Department of Neurology. From Dr. Picard’s webpage: “Dr. Picard’s translational research program investigates mechanisms of mitochondrial psychobiology.” https://www.columbianeurology.org/profile/mpicard
• Yaakov Stern (ys11@cumc.columbia.edu) Columbia University Department of Neurology. From Dr. Stern’s webpage: “Dr. Stern’s research focuses on cognition in normal aging and in diseases of aging, particularly Alzheimer’s disease. One strong focus of his current research program is investigating the neural basis of cognitive reserve. He is also conducting a large-scale imaging study to identify unique neural networks underlying the major cognitive abilities affected by aging.” https://www.cumc.columbia.edu/adrc/profile/ystern
• Kiran Thakur (ktt2115@cumc.columbia.edu) Columbia University Department of Neurology. From Dr. Thakur’s webpage: “Dr. Thakur’s research focuses on clinical and translational studies which aim to improve our ability to detect and manage neuroinfectious diseases and neuroinflammatory conditions in the hospital setting.” https://www.columbianeurology.org/profile/thakurt
• Carol Troy (cmt2@cumc.columbia.edu) Columbia University Department of Neurology. From Dr. Troy’s webpage: “The work in my laboratory stems from my long-standing interest in understanding the molecular specificity of death pathways.” https://www.pathology.columbia.edu/profile/carol-m-troy-md
• Sander Connolly (esc5@cumc.columbia.edu) Columbia University Department Neurological Surgery. From Dr. Connolly’s webpage: “… he serves as the Director of the Cerebrovascular Research Laboratory, which continues to be at the forefront of biomedical science, bringing the latest discoveries to the operating room and the patient bedside to not only treat but also prevent stroke.” https://www.columbianeurosurgery.org/doctors/e-sander-connolly-jr/
• Dani Dumitriu (idd2001@cumc.columbia.edu) Columbia University Department of Pediatrics. From Dr. Dumitriu’s webpage: “To tackle the mechanisms for individual variability in stress-responses, the DOOR lab uses several animal models, with the overarching unifying goal of understanding the structure, function, and developmental origins of resilience.” https://www.pediatrics.columbia.edu/profile/dani-dumitriu-md
• Harry R. Kissileff (Harry.Kissileff2@mountsinai.org) Dr. Kissileff’s lab at Mount Sinai Morningside, 114th St. & Amsterdam Ave, is currently analyzing data from a cohort of patients with morbid obesity who were studied before, and for 2 years following bariatric surgery, along with a cohort of normal individuals studied at 3 month intervals. Variables were collected to investigate the mechanism by which preoperative variables predicted weight loss. These variables measure cognitive, physiological, emotional, and behavioral factors that control appetite and food intake from a neurobehavioral perspective, and use the SAS statistical analysis system.
• Serge Przedborski (sp30@cumc.columbia.edu) Columbia University New York Motor Neuron Center. From Dr. Przedborski's webpage: "His ongoing research aims at understanding the contributions of cell-autonomous and non cell-autonomous mechanisms to neurodegeneration using both toxic and genetic experimental models of Parkinson's disease and Amyotrophic Lateral Sclerosis." https://www.vagelos.columbia.edu/departments-centers/motor-neuron-center/our-research/przedborski-lab
• Guang Yang (gy2268@cumc.columbia.edu) Columbia University Department of Anesthesiology. From Dr. Yang’s webpage: “My laboratory studies the mechanisms by which pathological immune responses contribute to neurological disorders such as chronic pain, Alzheimer’s disease and postoperative cognitive dysfunction. We focus on how immune cells and molecules regulate neural plasticity that is important for sensory processing and learning, and how anesthetics and sleep affect this process.” https://www.anesthesiology.cuimc.columbia.edu/profile/guang-yang-phd
• Yueqing Peng (yp2249@cumc.columbia.edu) Columbia University Institute of Genomic Medicine. From Dr. Peng’s webpage: “We use a multidisciplinary approach including electrophysiology, calcium imaging, optogenetics, chemogenetics, pharmacology, viral-based neural tracing, molecular biology, and mouse genetics to study the neurobiology of sleep.” https://www.pathology.columbia.edu/profile/yueqing-peng-phd
• Susana Mingote (sm2964@cumc.columbia.edu) Advanced Science Research Center, The Graduate Center CUNY. From Dr. Mingote’s webpage: “Dr. Mingote’s research in mice aims to understand how the brain forms and updates the memory of salient events to discriminate between harmful, rewarding, or neutral environments in both healthy and diseased conditions. Her group is particularly interested in how dopamine neuron projections to the lateral entorhinal cortex modulate memory of salience events, and how neuron-astrocyte interactions are involved in this memory process.” https://asrc.gc.cuny.edu/people/susana-mingote/
• Orie Shafer (oshafer@gc.cuny.edu) Advanced Science Research Center, The Graduate Center CUNY. From Dr. Shafer’s webpage: “Work in the Shafer lab seeks to understand how networks of clock neurons orchestrate rhythmic behavior. The Shafer lab employs anatomical, genetic, and live-imaging techniques in Drosophila to discover how time is kept within the brain and how it is used to orchestrate daily and seasonal changes in behavior.” https://www.shaferlab.org/
• Alison Goate (alison.goate@mssm.edu) Icahn School of Medicine at Mount Sinai. From Dr. Goate’s webpage: “Research in our laboratory focuses on dementia (Alzheimer’s disease & frontotemporal dementia) and addiction (alcohol dependence). In each of these projects our goal is to understand the molecular basis of disease in order to identify novel targets for therapeutic development. We use genetic and genomic approaches to identify susceptibility alleles, this work includes genome wide association studies and whole genome/exome sequencing in families multiply affected by disease and in case control cohorts.” https://icahn.mssm.edu/profiles/alison-m-goate
• Samuele Marro (samuele.marro@mssm.edu) Icahn School of Medicine at Mount Sinai. From Dr. Marro webpage: “My team focuses on synaptic plasticity and its dysfunction in Fragile X syndrome, the number one genetic cause of autism. As a tool, the group uses human neurons directly differentiated from pluripotent stem cells and genetically modified using CRISPR/Cas9 tools.” https://icahn.mssm.edu/profiles/samuele-giuseppe-marro